Productos

Laboratorios Bagó Pivalpen

Pivalpen

Forma Farmacéutica

Comprimidos Recubiertos.

Composición

Cada comprimido recubierto contiene:

Pimavanserina 34 mg (como Pimavanserina Tartrato 40 mg).

Acción Terapéutica

Antipsicótico (código ATC: N05AX17)

Indicaciones

Pivalpen está indicado para el tratamiento de las alucinaciones y delirios asociados con la psicosis de la enfermedad de Parkinson

Presentación

Envases por 30 comprimidos recubiertos redondos color blanco

Médicos
Array
(
    [ID] => 18959
    [post_author] => 17
    [post_date] => 2021-04-30 22:05:13
    [post_date_gmt] => 2021-05-01 01:05:13
    [post_content] => 

Forma Farmacéutica

Comprimidos Recubiertos.

Composición

Cada comprimido recubierto contiene: Pimavanserina 34 mg (como Pimavanserina Tartrato 40 mg).

Acción Terapéutica

Antipsicótico (código ATC: N05AX17)

Indicaciones

Pivalpen está indicado para el tratamiento de las alucinaciones y delirios asociados con la psicosis de la enfermedad de Parkinson

Presentación

Envases por 30 comprimidos recubiertos redondos color blanco [post_title] => Pivalpen [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => pivalpen [to_ping] => [pinged] => [post_modified] => 2021-06-14 14:11:33 [post_modified_gmt] => 2021-06-14 17:11:33 [post_content_filtered] => [post_parent] => 0 [guid] => https://www.bago.com.ar/vademecum/?post_type=productos&p=18959 [menu_order] => 0 [post_type] => productos [post_mime_type] => [comment_count] => 0 [filter] => raw [prospecto_para_pacientes] => Array ( [0] => WP_Post Object ( [ID] => 19032 [post_author] => 17 [post_date] => 2021-06-14 14:10:27 [post_date_gmt] => 2021-06-14 17:10:27 [post_content] => [post_title] => Info Paciente Pivalpen-jun2021 [post_excerpt] => [post_status] => inherit [comment_status] => open [ping_status] => closed [post_password] => [post_name] => info-paciente-pivalpen-jun2021 [to_ping] => [pinged] => [post_modified] => 2021-06-14 14:10:27 [post_modified_gmt] => 2021-06-14 17:10:27 [post_content_filtered] => [post_parent] => 0 [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2021/06/Info-Paciente-Pivalpen-jun2021.pdf [menu_order] => 0 [post_type] => attachment [post_mime_type] => application/pdf [comment_count] => 0 [filter] => raw ) ) [url_para_mayor_informacion_video] => [url_para_mayor_informacion] => [url_productos_consumo_masivo] => [prospecto] => Array ( [0] => WP_Post Object ( [ID] => 19031 [post_author] => 17 [post_date] => 2021-06-14 12:58:28 [post_date_gmt] => 2021-06-14 15:58:28 [post_content] => [post_title] => Prospecto Pivalpen-jun2021 [post_excerpt] => [post_status] => inherit [comment_status] => open [ping_status] => closed [post_password] => [post_name] => prospecto-pivalpen-jun2021 [to_ping] => [pinged] => [post_modified] => 2021-06-14 12:58:28 [post_modified_gmt] => 2021-06-14 15:58:28 [post_content_filtered] => [post_parent] => 0 [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2021/06/Prospecto-Pivalpen-jun2021.pdf [menu_order] => 0 [post_type] => attachment [post_mime_type] => application/pdf [comment_count] => 0 [filter] => raw ) ) [presentacion_img] => Array ( ) [logo_img] => Array ( ) [foto_producto] => Array ( [0] => WP_Post Object ( [ID] => 18988 [post_author] => 17 [post_date] => 2021-04-28 16:07:47 [post_date_gmt] => 2021-04-28 19:07:47 [post_content] => [post_title] => pivalpen-banner [post_excerpt] => [post_status] => inherit [comment_status] => open [ping_status] => closed [post_password] => [post_name] => pivalpen-banner [to_ping] => [pinged] => [post_modified] => 2021-04-28 16:07:47 [post_modified_gmt] => 2021-04-28 19:07:47 [post_content_filtered] => [post_parent] => 18959 [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2021/02/pivalpen-banner.png [menu_order] => 0 [post_type] => attachment [post_mime_type] => image/png [comment_count] => 0 [filter] => raw ) ) [fotos_lanzamiento] => Array ( ) [especialidad] => Array ( ) [marca] => Array ( [0] => Pivalpen ) [principio_activo] => Array ( [0] => Pimavanserina ) [post_content_formatted] =>

Forma Farmacéutica

Comprimidos Recubiertos.

Composición

Cada comprimido recubierto contiene:

Pimavanserina 34 mg (como Pimavanserina Tartrato 40 mg).

Acción Terapéutica

Antipsicótico (código ATC: N05AX17)

Indicaciones

Pivalpen está indicado para el tratamiento de las alucinaciones y delirios asociados con la psicosis de la enfermedad de Parkinson

Presentación

Envases por 30 comprimidos recubiertos redondos color blanco

)

Información del producto

Array
(
    [_wp_attached_file] => Array
        (
            [0] => prospectos/Prospecto-Pivalpen-jun2021.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:5:"sizes";a:4:{s:4:"full";a:4:{s:4:"file";s:34:"Prospecto-Pivalpen-jun2021-pdf.jpg";s:5:"width";i:1088;s:6:"height";i:10753;s:9:"mime-type";s:10:"image/jpeg";}s:6:"medium";a:4:{s:4:"file";s:41:"Prospecto-Pivalpen-jun2021-pdf-30x300.jpg";s:5:"width";i:30;s:6:"height";i:300;s:9:"mime-type";s:10:"image/jpeg";}s:5:"large";a:4:{s:4:"file";s:43:"Prospecto-Pivalpen-jun2021-pdf-104x1024.jpg";s:5:"width";i:104;s:6:"height";i:1024;s:9:"mime-type";s:10:"image/jpeg";}s:9:"thumbnail";a:4:{s:4:"file";s:41:"Prospecto-Pivalpen-jun2021-pdf-15x150.jpg";s:5:"width";i:15;s:6:"height";i:150;s:9:"mime-type";s:10:"image/jpeg";}}}
        )

)
Ver Prospecto >
Array
(
    [_wp_attached_file] => Array
        (
            [0] => 2021/06/Info-Paciente-Pivalpen-jun2021.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:5:"sizes";a:4:{s:4:"full";a:4:{s:4:"file";s:38:"Info-Paciente-Pivalpen-jun2021-pdf.jpg";s:5:"width";i:1088;s:6:"height";i:3931;s:9:"mime-type";s:10:"image/jpeg";}s:6:"medium";a:4:{s:4:"file";s:45:"Info-Paciente-Pivalpen-jun2021-pdf-83x300.jpg";s:5:"width";i:83;s:6:"height";i:300;s:9:"mime-type";s:10:"image/jpeg";}s:5:"large";a:4:{s:4:"file";s:47:"Info-Paciente-Pivalpen-jun2021-pdf-283x1024.jpg";s:5:"width";i:283;s:6:"height";i:1024;s:9:"mime-type";s:10:"image/jpeg";}s:9:"thumbnail";a:4:{s:4:"file";s:45:"Info-Paciente-Pivalpen-jun2021-pdf-42x150.jpg";s:5:"width";i:42;s:6:"height";i:150;s:9:"mime-type";s:10:"image/jpeg";}}}
        )

)
Ver Información para Pacientes >

Bibliografía

Ver todos >
anexo_congre_single

ADVERTENCIA:

El material incluido en este sitio ha sido concebido exclusivamente para los profesionales de la salud con fines informativos, y destinado a orientar sobre el uso adecuado de los medicamentos y a satisfacer sus necesidades de mayor información.

Todos los textos referidos a nuestros productos de venta bajo prescripción médica se corresponden a los lineamientos aprobados por la Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT).

Laboratorios Bagó le sugiere consultar siempre a un profesional de la salud calificado ante cualquier duda sobre una condición médica particular.

He comprendido y deseo ver la información

Consultas médicas: infoproducto@bago.com.ar